SR
Sanjeev Roy
About Sanjeev Roy
Data last updated:
Sanjeev Roy is a Director at Brugen Pharmaceuticals Private Limited (since 2020). The companies operate in Chemicals and Events and Entertainment. Brugen Pharmaceuticals Private Limited reported revenue of ₹11.2 Lakh (FY 2025). Earlier, Sanjeev Roy was an Additional Director at Ramuji Water Park Private Limited (2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brugen Pharmaceuticals Private Limited U24297MP2020PTC053281 | Director | 14 Oct 2020 | 2020 | ₹11.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ramuji Water Park Private Limited U92190MP2017PTC044141 | Additional Director | 01 Mar 2018 | 2017 | ₹1.02 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjeev Roy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prabha Roy | 08919513 | Brugen Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjeev Roy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjeev Roy
Sanjeev Roy currently holds 1 directorship: Brugen Pharmaceuticals Private Limited (Director, since 14 Oct 2020, revenue ₹11.2 Lakh (FY 2025)).
Sanjeev Roy was first appointed on 01 Mar 2018 as Additional Director at Ramuji Water Park Private Limited. The most recent appointment on record is 14 Oct 2020 at Brugen Pharmaceuticals Private Limited.
Sanjeev Roy held 1 earlier board appointment: Ramuji Water Park Private Limited (Additional Director, 01 Mar 2018 to 01 Nov 2018).
The current boards of Sanjeev Roy's companies include Prabha Roy (Brugen Pharmaceuticals Private Limited).